
|Articles|May 1, 2008
New Product: Aerocrine's Niox Mino
The first FDA-approved device to measure airway inflammation in asthma patients.
Advertisement
Newly approved airway inflammation hand-held device
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
AAP recommends 2026-2027 COVID-19 vaccine for all infants 6 to 23 months and at-risk older children
2
AAP expands RSV immunization recommendations for high-risk children
3
The future of PMOS care: GLP-1 therapy and weight-loss caution
4
The unharmonious 2026 child and adolescent immunization schedule - addendum
5






